| |
NAMD (Medicaid Association) Letter Urges
Congress to Address Break Through Drugs
|
| |
| |
Download the PDF here
Post date:
October 28, 2014
Today the National Association of Medicaid Directors sent the attached letter to the leaders of the Senate Finance and HELP and House Energy & Commerce and Ways & Means committees regarding the current situation with break through prescription drug treatments. The letter addresses the challenges presented by new hepatitis C treatments. It focuses on issues pertinent to state Medicaid programs, though it recognizes this issue impacts all government programs and other payers as well as patients. It also calls on Members of Congress to begin a dialogue on break through drug pricing issues and to advance pragmatic solutions that balance the needs of patients and the costs for Medicaid.
http://medicaiddirectors.org/node/1083
"A separate federal program created for the sole purpose of financing the provision of this drug to the affected population, similar to the Ryan White and state ADAP programs for HIV/AIDS drugs, with Medicaid serving as a payer of last resort"
|
|
| |
| |
|
|
|
